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Abstract
Purpose The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making 
(SDM); patients’ emotional distress, and coping in subjects with resected, non-metastatic cancer.
Methods 602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient 
satisfaction with SDM, participants’ emotional distress and coping, as well as patient sociodemographic and clinical char-
acteristics by means of specific, validated questionnaires.
Results Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness 
or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a 
higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 
vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I–II (28 
vs 18%).
Conclusion Physicians must be mindful of the importance of emotional support and individual characteristics when com-
municating treatment options, benefits, and adverse effects of each alternative to oncological patients.
Keywords Cancer · Coping · Distress · Medical oncologist · Satisfaction · Shared decision-making
Introduction
In recent years, 30–40% of cancer patients have been seen 
to present emotional distress and maladaptive coping strate-
gies [1]. The confirmation of diagnosis of cancer has a huge 
emotional impact that generates fear, anxiety, uncertainty, 
sadness, and anger. The treatments generally applied to can-
cer, such as surgery, chemotherapy, and radiotherapy, tend 
to entail multiple side effects and decline in the patient’s 
physical and emotional status [1]. Given that psychological 
 * P. Jimenez-Fonseca 
 palucaji@hotmail.com
1 Department of Medical Oncology, Hospital Universitario 
Central de Asturias, Planta-1, Bloque D, Avenida Roma sn, 
33011 Oviedo, Spain
2 Department of Clinical Psychology and Psychobiology, 
Faculty of Psychology, University of Barcelona, Barcelona, 
Spain
3 Department of Hematology and Medical Oncology, Hospital 
Universitario Morales Meseguer, Murcia, Spain
4 Department of Medical Oncology, Hospital Virgen de La 
Luz, Cuenca, Spain
5 Department of Medical Oncology, Hospital Universitario de 
Canarias, Tenerife, Spain
6 Department of Medical Oncology, Hospital Universitario 
Son Espases, Mallorca, Spain
7 Department of Medical Oncology, Hospital Universitario La 
Paz, Madrid, Spain
8 Department of Medical Oncology, Hospital Universitario 
Virgen de La Macarena, Sevilla, Spain
9 Department of Medical Oncology, Hospital Universitario 
Marqués de Valdecilla, Santander, Spain
10 Department of Medical Oncology, Hospital Universitario del 
Sureste, Arganda del Rey, Madrid, Spain
11 Department of Medical Oncology, Hospital Universitario 
Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, 
Spain
 Clinical and Translational Oncology
1 3
distress and psychosocial problems appear to negatively 
affect oncological patient’s quality of life, screening and 
assessing these issues should be a routine in clinical prac-
tice [2, 3]. However, little attention is paid in our setting, 
with few large, multicenter studies conducted in Spain. For 
instance, the Southern European Psycho-Oncological Study 
(SEPOS) revealed that Spanish and Italian individuals with 
cancer displayed higher levels of anxiety and depression and 
lower levels of resignation compared to their Portuguese 
counterparts, in addition to lower levels of spirituality [2, 4].
Another factor is the repercussions of distress and psy-
chosocial problems on the physician–patient relationship, 
potentially affecting communication between them [2, 5]. 
The individual’s interaction with their oncologist influences 
how they experience their illness on many levels. Some stud-
ies point to a correlation between a lack of ability on the 
physician’s part to listen and respond to patients’ emotional 
concerns and needs and patients’ dissatisfaction [6] and 
worse quality of life [7]. In line with these findings, oncolo-
gists’ attention and emotional support and their attitude 
toward the patient enhance satisfaction [7, 8], coping, and 
emotional well-being [9, 10]. Patient characteristics, such 
as gender, age, tumor type, or stage of disease, as well as 
their coping styles and emotional status also influence this 
well-being. Likewise, all of these factors influence the doc-
tor–patient relationship.
With this background and with the aim of expanding our 
understanding in this area, the objective of this study was to 
analyze differences in physician and patient satisfaction with 
shared decision-making (SDM), as well as patients’ emo-
tional distress and coping based on gender and age, and on 
the basis of the location of the tumor and the stage of disease 
in a sample of Spanish patients with resected, non-metastatic 
cancer who were going to receive adjuvant chemotherapy.
Methods
The study was conducted at the department of Medical 
Oncology at 14 hospitals in Spain. Patients completed self-
report questionnaires prior to initiating chemotherapy. The 
study was approved by the Ethics Review Board at each 
institution and by the Spanish Agency of Medicines and 
Medical Devices (AEMPS). Specifically trained medical 
oncologists collected and updated data, via a web-based 
platform (http://www.neoco ping.es). Of the 687 patients 
screened, 85 were not eligible (17 did not meet inclusion 
criteria; 23 met exclusion criteria; and 45 had incomplete 
data).
Physicians’ satisfaction was measured with the SDM 
Questionnaire-Physician’s version (SDM-Q-Doc), a ques-
tionnaire that evaluates the physician’s perspective on SDM 
and how well they follow it with their patients [11]. It was 
adapted to Spanish by Calderon et al. [12] and subsequently 
validated. It consists of nine items, each of which describes 
one step of the process. The items are scored from 0 to 5 
on a six-point Likert scale as “completely disagree” (0) to 
“completely agree” (5). A simple sum score ranging from 
0 to 45 is obtained and shows good internal consistency in 
Spain (α = 0.90) [12].
Patients’ satisfaction was measured with the SDM Ques-
tionnaire-Patient’s version (SDM-Q-9), a brief, valid, reli-
able questionnaire that evaluates the SDM process from the 
patient’s perspective [13], adapted to Spanish by De las Cue-
vas et al. [14]. It contains nine items, each describing one 
step of the SDM process [15] and was developed to assess 
the degree to which patients feel involved in the decision-
making process. Items are scored from 0 to 5 on a six-point 
Likert scale (5). Standard scoring is a simple summary score 
with possible values between 0 and 45; the scale has proven 
good internal consistency in Spain (α = 0.88) [14]. Both 
scales (SDM-Q-Doc and SDM-Q-9) were dichotomized at 
the mean plus one standard deviation to differentiate satis-
fied from dissatisfied cases. This criterion results in biased 
distributions but should be considered as “the standard” in 
this context.
The Mini-Mental Adjustment to Cancer (Mini-MAC) 
scale [16] was used to assess patients’ cognitive and behav-
ioral attitude toward cancer, specifically hopelessness and 
anxious preoccupation [17]. Both subscales consist of eight 
items, the first measuring the tendency to adopt a pessimis-
tic, despairing attitude regarding the illness and the second 
one that rates the tendency to feel worried and preoccupied 
about the disease. Each item is rated on a 4-point Likert 
scale. Scores for both hopelessness and anxious preoccupa-
tion varied from 0 to 24 and cutoff scores for these items 
(mean score ± 1 SD) were used to identify cases of maladap-
tive coping, as per the MAC user’s manual [16].
Emotional distress was appraised by the Brief Symptom 
Inventory (BSI), one of the most widely used instruments 
to rate emotional distress in clinical patients [18] consisting 
of 18 items. Each item is scored on a 5-point Likert scale. 
Scores for each subscale range from 0 to 24. Raw-scores are 
converted to T-scores based on gender-specific normative 
data from a non-patient population, with higher scores indi-
cating greater anxiety or depression. To identify individuals 
with significant emotional distress, the BSI-18 applies the 
clinical case rule [19], originally developed for the SCL-90. 
According to the BSI-18 Manual, respondents with a T-score 
≥ 63 should be classified as having clinically significant dis-
tress. The Spanish version of BSI has good reliability and 
validity in Spanish patients [20].
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Data analysis
Distribution and frequency analyses were used to evaluate 
the sample. The relationships between clinical and demo-
graphic factors and the presence of physician and patient 
satisfaction/dissatisfaction with SDM; patients’ maladaptive 
coping, and emotional distress were tested using Chi-square 
and t test or ANOVA (F). The χ2 test was used to compare 
categorical variables between the different patient groups; 
t test or ANOVA (F) for independent samples was used to 
compare continuous variables. Univariate models were fit-
ted for all clinical and demographic variables: gender (male/
female), age (≤ 44, 45–54, 55–64, 65–74, ≥ 75 years), tumor 
(colorectal, breast, stomach, and others), and stage (I–II/III). 
A raw-score ≤ 27 was used to identify physicians’ dissatis-
faction, while a raw-score ≤ 20, indicated patients’ dissat-
isfaction. In patients, a raw-score ≥ 9 established hopeless-
ness and a raw-score ≥ 16 identified anxious preoccupation. 
Analyses were conducted using SPSS 23.0 version and an 
alpha level of 0.05.
Results
A total of 602 patients participated in the study (244 with 
colorectal, 203 with breast, 38 with stomach, and 117 with 
other cancers). The mean age was 59 ± 12 years. Most par-
ticipants were female (n = 358, 60%), married or lived with a 
partner (77%), and had completed primary education (56%). 
The most common employment status was retired (59%) (see 
Table 1 for details).
Physicians’ general characteristics are reported elsewhere 
[12]. In summary, patients were recruited by 30 medical 
oncologists from 14 Spanish hospitals; 78.1% (n = 25) of 
these specialists were female; mean age was 35 ± 7.4 years, 
with 11.9 ± 8.8 years of experience in caring for cancer 
patients. Most were super-specialists (68.8%) working at a 
public, teaching hospital (53.1%).
Physician–patient satisfaction and psychological 
variables by gender and age
In the sample as a whole, 11% of physicians and 19% 
of patients were dissatisfied with SDM; while among 
patients, 22% displayed hopelessness or anxious preoccu-
pation as coping strategies, and 56% exhibited emotional 
distress.
Table 2 presents the descriptive results for the psycho-
logical scales separated by gender and age. Insofar as phy-
sician–patient interaction is concerned, physicians’ satis-
faction with SDM did not differ according to the patients’ 
gender or age. In contrast, patient satisfaction differed by 
gender, in that males scored higher on satisfaction with 
SDM (t(600) = 3.980, p < 0.001), whereas among women, 
dissatisfaction was more prevalent than among men (23 vs 
14%, χ2 = 8.704, p = 0.003; odds ratio (OR) = 1.930, 95% 
confidence interval (CI) 1.241–3.001).
Regarding coping, females showed a slightly higher 
prevalence of anxious preoccupation than males (26 
vs 17%; χ2 = 6.670, p = 0.010, OR = 1.712, 95% CI 
1.135–2.583), and higher scores on AP (t(600) = − 2.507, 
p = 0.012), but no differences were detected in hope-
lessness between males and females. Younger patients 
exhibited lower scores on hopelessness (F(4,596)=3.125, 
p = 0.015) and higher scores on anxious preoccupation 
(F(4,597) = 2.592, p = 0.036); participants aged ≤ 44 years 
presented more anxious preoccupation and less hopeless-
ness than those 65 years of age or older.
As regards to the BSI, females displayed a higher preva-
lence rate of emotional distress than males (63 vs 44%; 
χ2 = 19.410, p < 0.001, OR = 2.095, 95% CI 1.505–2.918) 
and scored higher for emotional distress (t(600) = − 5.926, 
p < 0.001). The prevalence of cases of emotional distress 
as per the BSI (cut-off ≥ 63) differed across the five age 
groups (χ2 = 24.864, p < 0.001). Subjects 44 years of age or 
younger suffered more emotional distress than those aged 
≥ 65 years (F(4,597) = 8.676, p < 0.001).
Table 1  Patient demographic and clinical characteristics according to the location of the cancer
M mean, SD standard deviation
Patient demographic and 
clinical characteristics
Colorectal (n = 244)
N (%)
Breast (n = 203)
N (%)
Stomach (n = 38)
N (%)
Others (n = 117)
N (%)
Total (n = 602)
N (%)
Gender (% women) 90 (37) 198 (94) 15 (39) 55 (47) 358 (60)
Age, M (SD) 63.1 (11.1) 52.9 (10.8) 65.1 (9.9) 59.4 (12.8) 59.1 (12.2)
Marital status (% married) 195 (80) 148 (73) 31 (82) 87 (74) 461 (77)
Education (% primary) 146 (60) 106 (52) 24 (63) 61 (52) 337 (56)
Work (% retired) 165 (68) 88 (43) 28 (74) 71 (61) 352 (59)
Stage
 I–II 84 (35) 181 (89) 11 (29) 60 (61) 336 (58)
 III 159 (65) 22 (11) 27 (71) 38 (39) 246 (42)
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Physician–patient satisfaction and psychological 
variables by tumor and stage
Table 3 shows the descriptive results for the psychologi-
cal scales separated by tumor and stage. As far as physi-
cians’ (F(3,598) = 4.138, p = 0.006) and patients’ satisfaction 
(F(3,615) = 3.825, p = 0.010) with the SDM, significant dif-
ferences were revealed when examined by tumor. Physi-
cians were more satisfied with SDM, as were colon cancer 
patients, whereas individuals with stomach and breast cancer 
were the least satisfied. There were no differences in patient 
satisfaction with the SDM based on tumor stage, although 
doctors displayed greater satisfaction with stage I–II cancer 
patients (t(580) = 3.723, p < 0.001).
Insofar as coping and emotional distress are concerned, 
patients with stomach cancer scored highest on hopeless-
ness (F(3,598) = 4.854, p = 0.002) and emotional distress 
(F(3,598) = 7.113, p < 0.001). Not only did patients with 
stage III cancer display a higher prevalence of hopelessness 
compared with patients with tumor staged I–II (28 vs 18%; 
χ2 = 7.323, p = 0.07, OR = 1.722, 95% CI 1.159–2.558), 
were also seen to display more intense hopelessness 
(t(580) = − 2.771, p = 0.006), and anxious preoccupation 
(t(580) = − 2.285, p = 0.023) scores were higher in the group 
of participants with stage III tumors, albeit no differences 
were found in emotional distress. See Fig. 1.
Discussion
This study examines physician and patient dissatisfaction 
with SDM, and patients’ emotional distress and maladaptive 
coping styles, taking into account patient demographic and 
clinical variables.
With respect to the primary objective of this study, dis-
satisfaction with SDM was only present in one out of every 
ten physicians and one in five patients. These data are con-
gruent with those of other studies that show that oncological 
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patients in our setting are not terribly interested in participat-
ing in making decisions that affect their health and points to 
this being affected in part, by a paternalistic model that con-
tinues to exist in most Spanish hospitals [21, 22]. We also 
believe that not all oncological patients are prepared or even 
want to be equally involved or participate in SDM at times of 
great emotional tension. On the other hand, men and patients 
with colon cancer are the ones who are most satisfied with 
SDM, whereas women and subjects with breast cancer were 
the least satisfied.
Half of all patients exhibit psychological distress and, of 
them, it reaches levels between moderate and severe in one-
third; as such, they would require clinical care. This datum 
is in line with other studies that prove that the symptoms 
of psychological distress should be assessed throughout the 
entire course of their cancer [23]. Likewise, females exhib-
ited greater distress than males (63 vs 44%); patients under 
the age of 44 more than those ≥ 65 years of age (66 vs 42%), 
and those with stomach cancer more than the participants 
with colon cancer (68 vs 43%). Of the sociodemographic 
variables, age and gender have been widely analyzed. Stud-
ies report that young people tend to develop psychologi-
cal distress more often [24, 25], whereas women exhibit a 
greater sense of threat and emotional impact in the form of 
distress or post-traumatic stress than men [26, 27].
Apropos coping, approximately one in every four patients 
reported maladaptive coping strategies; specifically, hope-
lessness and anxious preoccupation, confirming the need to 
integrate psychosocial help into clinical practice as a way of 
improving quality of care for individuals with cancer [28]. 
As indicated in other studies, younger patients were the ones 
who confront cancer worse, presenting more hopelessness 
and psychological distress [29, 30]. Females, and in par-
ticular, those with breast cancer, were also the ones who 
displayed more psychological distress and anxious preoc-
cupation [31, 32], and patients with stage III stomach cancer 
presented the most hopelessness.
This study is not without its limitations that must be taken 
into consideration. First of all, the use of self-report, subjec-
tive measures cannot accurately reflect patients’ experiences, 
expectations, and behaviors, as they are limited by response 
bias (social desirability, inaccurate memory, etc.). Second, 
we have not factored in physician-based variables, such as 
age, gender, personality (e.g., empathic attitude, locus of 
control), or burnout, that have an important influence on the 
physician–patient relationship and on patient satisfaction [8]. 
Likewise, we have not taken into account variables, such as 
the characteristics of patients’ personality, social and family 
support, or prior stressful events when accounting for patient 
satisfaction [33] and that should be taken into consideration 
in future research.
Clinical repercussions
Our study suggests that, bearing in mind the high prev-
alence of emotional distress and maladaptive strategies 
among oncological patients, doctors should contemplate 
Table 3  Perception of physician–patient interaction (SDM), emotional distress (BSI), and coping (Mini-MAC) by tumor and stage
a Questionnaire-Patient’s version (SDM-Q-9)
b Questionnaire-Physician’s version (SDM-Q-Doc)
Tumors Stage
Colon (n = 244) Breast (n = 203) Stomach (n = 38) Others (n = 117) p value I–II (n = 336) III (n = 246) p value
Patients’ satisfaction 
with  SDMa
33.1 (4.3) 32.6 (5.1) 31.4 (6.8) 31.2 (5.5) 0.006 33.2 (5.1) 31.7 (4.4) 0.001
Physician’s satisfaction 
with  SDMb
29.2 (7.9) 26.9 (9.1) 30.6 (6.9) 28.3 (8.1) 0.010 28.5 (8.2) 28.2 (8.4) ns
Hopelessness 4.6 (4.4) 4.0 (4.2) 6.7 (4.5) 5.2 (4.6) 0.002 4.2 (4.2) 5.2 (4.5) 0.006
Anxious preoccupation 9.8 (6.1) 10.4 (6.1) 11.3 (5.5) 10.6 (6.1) ns 9.8 (6.1) 10.9 (6.1) 0.023
Emotional distress 62.3 (6.5) 64.8 (6.9) 65.1 (6.1) 64.9 (6.3) 0.001 63.9 (6.6) 63.7 (6.9) ns
Physicians’ dissatisfac-
tion ≤ 27
7 13 16 15 0.044 10 12 ns
Patients’ dissatisfaction 
≤ 20
16 25 13 19 ns 19 20 ns
Caseness for hopeless-
ness (≥ 9)
23 15 37 28 0.005 18 28 0.007
Caseness for anxious 
preoccupation (≥ 16)
19 24 21 28 ns 22 23 ns
Caseness for emotional 
distress (≥ 63)
43 64 68 64 0.001 57 52 ns
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these variables when treating their patients and adapt 
their communication style accordingly. Young people 
and females generally perceive cancer as more aggres-
sive and disruptive, not only because of its worse progno-
sis, but also because the diagnosis at a young age breaks 
with the natural and social history that tends to associate 
disease and demise with being elderly. We must also be 
mindful of the cultural aspects that need to be taken into 
account when analyzing psychosocial variables and in 
communication skills training when applied in a clinical 
context [33]. If we are to provide better quality of care, we 
must consider the patient’s context and characteristics, as 
well as those of the cancer during screening, evaluation, 
and treatment.
Funding The study was supported by the FSEOM-Onvida for Projects 
on Long Survivors and Quality of Life. SEOM (Spanish Society of 
Medical Oncology) 2015.
Fig. 1  Perception of physi-
cian–patient interaction (SDM), 
emotional distress (BSI), and 
coping (Mini-MAC) by patient 
demographic (gender and age) 
and clinical (tumor and stage) 
characteristics. The data are 
presented in percentages
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